Our clients include world's top universities and pharmaceutical organizations
Affimed
Saturday, June 3, 2023
Affimed Presents AFM24 Monotherapy Data in Non-Small Cell Lung Cancer at the Annual Meeting of the American Society of Clinical Oncology and Provides Strategic Update on AFM24 Development Plan
Affimed
Saturday, June 3, 2023
Affimed Presents AFM24 Monotherapy Data in Non-Small Cell Lung Cancer at the Annual Meeting of the American Society of Clinical Oncology and Provides Strategic Update on AFM24 Development Plan
Intensity Therapeutics
Saturday, June 3, 2023
Intensity Therapeutics’ INT230-6 Prolongs Survival Alone or in Combination With Ipilimumab in Adult Patients with Relapsed, Refractory, Metastatic Sarcomas
Immunocore
Saturday, June 3, 2023
Immunocore presents additional ctDNA data from the KIMMTRAK Phase 3 trial at ASCO
American Transplant Congress 2023
Saturday, June 3, 2023
San Diego Convention Center,San Diego, CA, USA.
Nature Medicine
Friday, June 2, 2023
Pembrolizumab in brain metastases of diverse histologies: phase 2 trial results
Science
Friday, June 2, 2023
Heart-brain connections: Phenotypic and genetic insights from magnetic resonance images
Nature Medicine
Thursday, June 1, 2023
Genomic profiling informs diagnoses and treatment in vascular anomalies
Nature Medicine
Thursday, June 1, 2023
Genetically adjusted PSA levels for prostate cancer screening
Precigen
Saturday, June 3, 2023
Precigen Announces Positive Phase 1 Data for Off-the-Shelf PRGN-2009 AdenoVerse™ Immunotherapy Alone and in Combination with an Investigational Checkpoint Inhibitor in Patients with Recurrent/Metastatic HPV-associated Cancers
Gilead Sciences
Saturday, June 3, 2023
Gilead and Arcus Announce Anti-TIGIT Domvanalimab Continues to Demonstrate Consistent Improvement in Progression-Free Survival in Non-Small Cell Lung Cancer Study
Arcus Biosciences
Saturday, June 3, 2023
Gilead and Arcus Announce Anti-TIGIT Domvanalimab Continues to Demonstrate Consistent Improvement in Progression-Free Survival in Non-Small Cell Lung Cancer Study
Annual Congress of the European Hematology Association 2023
Thursday, June 8, 2023
Frankfurt, Germany
European Academy of Allergy and Clinical Immunology Congress 2023
Friday, June 9, 2023
Hamburg, Germany
Science
Thursday, June 1, 2023
A functional group–guided approach to aptamers for small molecules
Science
Thursday, June 1, 2023
Body-based units of measure in cultural evolution
Science
Thursday, June 1, 2023
Rhythmic cilia changes support SCN neuron coherence in circadian clock
IGM Biosciences
Saturday, June 3, 2023
IGM Biosciences Announces Update on IGM-8444 Phase 1 Trial and Future Clinical Development
Akebia Therapeutics
Friday, June 2, 2023
Akebia Therapeutics to Present at Jefferies Healthcare Conference
Can Fite Biopharma
Friday, June 2, 2023
Can-Fite to Participate in Out-licensing and Distribution Partnering Meetings at Bio International Convention in Boston
Swedish Orphan Biovitrum
Friday, June 2, 2023
Sobi to present new data at the 2023 EHA congress
2023 American College of Veterinary Internal Medicine (ACVIM) Forum
Thursday, June 15, 2023
Philadelphia, Pennsylvania
Nature
Wednesday, May 31, 2023
Deterministic evolution and stringent selection during preneoplasia
Vanda Pharmaceuticals
Friday, June 2, 2023
Vanda Pharmaceuticals Announces Presentations at SLEEP 2023
Vanda Pharmaceuticals
Friday, June 2, 2023
Vanda Pharmaceuticals Announces Orphan Drug Designation Granted for VCA-894A, a Novel Antisense Oligonucleotide Candidate for the Treatment of Charcot-Marie-Tooth Disease, Type 2S
Legend Biotech
Friday, June 2, 2023
Legend Biotech Announces Participation in Upcoming Investor Conferences
X4 Pharmaceuticals
Friday, June 2, 2023
X4 Pharmaceuticals Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
American Headache society 65th Annual Scientific Meeting
Thursday, June 15, 2023
JW Marriott Austin
Austin, TX
Nature
Wednesday, May 31, 2023
Axonemal structures reveal mechanoregulatory and disease mechanisms
Nature
Wednesday, May 31, 2023
Pan-KRAS inhibitor disables oncogenic signalling and tumour growth
Nature
Wednesday, May 31, 2023
Indefinite and bidirectional near-infrared nanocrystal photoswitching
Nature
Wednesday, May 31, 2023
Transfer learning enables predictions in network biology
Arctom provides 200,000+ Building Blocks, Inhibitors/Agonists, Natural Products, PEG Linkers, and other Research Chemicals from our own and partners' stock for global pharmaceutical, biotech, research, and industrial customers.